N@N

Bill Sutherland Reiterated (AMED) at Strong Buy and Held Target at $120 on, Feb 13th, 2023

^{Published on 2024-10-28 01:34:24 - WOPRAI, Bill Sutherland}
 

Bill has made no other calls on AMED in the last 4 months.

There are 10 other peers that have a rating on AMED. Out of the 10 peers that are also analyzing AMED, 3 agree with Bill's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $85 on, Thursday, January 5th, 2023
• Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $106 on, Friday, November 11th, 2022
• John Ransom of "Raymond James" Downgraded from Buy to Hold on, Thursday, October 27th, 2022

These are the ratings of the 7 analyists that currently disagree with Bill

• Jonathan Yong of "Credit Suisse" Maintained at Buy with Decreased Target to $115 on, Monday, January 23rd, 2023
• Colin Rusch of "Oppenheimer" Maintained at Buy with Decreased Target to $125 on, Thursday, January 19th, 2023
• Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $139 on, Monday, October 31st, 2022
• David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $130 on, Friday, October 28th, 2022
• Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $145 on, Friday, October 28th, 2022
• Sarah James of "Barclays" Maintained at Buy with Decreased Target to $126 on, Friday, October 28th, 2022
• Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $165 on, Monday, October 24th, 2022